Stock Track | Inari Medical Soars in Pre-Market on Strong Q3 Results and Upbeat Outlook

Stock Track10-29

Inari Medical, Inc. (NASDAQ: NARI) shares surged 8.06% in pre-market trading on October 29, 2024, following the company's impressive third-quarter financial results and raised full-year revenue guidance.

For the third quarter ended September 30, 2024, Inari Medical reported revenue of $153.4 million, representing a 21.4% increase compared to the same period last year. The strong revenue growth was driven by an expansion in sales territories, opening of new accounts, increased adoption of the company's procedures, global commercial expansion, and the introduction of new products.

Notably, Inari Medical's revenue figure surpassed analysts' expectations, and the company raised its full-year 2024 revenue guidance to a range of $601.5 million to $604.5 million, reflecting an increase of $3.5 million at the midpoint from its prior outlook. The company also expects to achieve sustained operating profitability in the first half of 2025, indicating an improved profitability outlook.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment